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Although  chloramphenicol is  known  to inhibit microbial protein synthesis 
both in intact cells (1-3)  and in cell-free systems  (4--8),  similar inhibition of 
protein  synthesis  does  not  occur  in  analogous  mammalian  systems  unless 
large  amounts  of  chloramphenicol  are  employed  (9-12).  The  difference  in 
sensitivity to chloramphenicol is most striking in cell-free systems, where cellu- 
lar permeability is not a factor. Thus complete inhibition of protein synthesis 
in Esckerichia  coli  cell-free systems can be obtained with 0.15 micromoles of 
chloramphenicol per ml reaction mixture (7). In contrast, comparatively little 
inhibition of protein synthesis in mammalian  cell-free systems has  been ob- 
tained with 5  to 10 micromoles of the drug per ml reaction mixture (10,  11). 
The findings of Djordjevic and Szybalski (13) and of Ambrose and Coons (14) 
appear to be exceptions to these observations. In  these studies inhibition of 
protein synthesis was obtained in tissue cultures with low levels of chloram- 
phenicol providing the drug was in  contact with  the  cells during periods  of 
active protein synthesis. 
Despite the difference in sensitivity to chloramphenicol, the requirements for pro- 
tein  synthesis  in both microbial  and  mammalian cell-free systems  are remarkably 
similar  and the components  involved are even interchangeable  (15, 16). The mech- 
anism  by which  chloramphenicol  inhibits protein synthesis  in cell-free systems  has 
been studied  intensively.  It has been found that chloramphenicol does not affect the 
activation  of amino  acids or the formation of amino  acyl soluble RNA  (s-RNA)  in 
either mammalian or bacterial cell-free systems (8, 18). In bacterial cell-free systems, 
however, it  has  been demonstrated that chloramphenicol interferes with the  transfer 
of amino  acids from soluble RNA to ribosomes (8, 17, 18). Since chlorarnphenicol does 
not appear to inhibit this step in mammalian  systems, it has been suggested that the 
difference  in  sensitivity of microbial  and mammalian  cell-free systems  to  chloram- 
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phenicol may be due to a selective effect of the drug on bacterial  ribosomes and  that 
this selective effect may be due to functional differences in the ribosomes. Von Ehren- 
stein and Lipmann have suggested the possibility that the difference in sensitivity may 
be due to the presence  in bacteria of an extra, drug-sensitive  step involved  in  the 
transfer of amino acids from soluble RNA to ribosomes (11). 
Although there is no recognizable effect of chloramphenicol on protein synthesis by 
mammalian  cells  (with the exception  of the aforementioned  tissue  culture experi- 
ments), hematopoiefic depression  attributable to chloramphenicol  is a  well known 
phenomenon (19-21). The mechanism by which chloramphenicol exerts a toxic effect 
on human hematopoietic cells remains unknown but can be correlated with high blood 
concentrations (23, 24) and impaired clearance of the drug (22). Hematopoietic toxicity 
is also increased in certain conditions characterized  by the presence of immature or 
proliferating  erythrocytes. Saidi,  Wallerstein,  and  Aggeler  (25) have  shown  that 
administration of chloramphenicol to patients with pernicious anemia in relapse blocks 
the reticulocyte response to vitamin B12. A similar lack of reticulocyte response was 
observed in patients with iron deficiency anemia receiving chloramphenicol during iron 
therapy. Since inhibition occurs uniformly during the proliferative phases of erythro- 
poiesis it would appear that primitive erythrocytes are markedly susceptible to chlor- 
amphenicol  inhibition,  whereas  cells at  a  later stage  of maturation are relatively 
resistant. 
The  observations  on  the  sensitivity  of  immature  erythrocytes  to  chlor- 
arnphenicol provide an  approach  to  studying  the  discrepancy between  the 
effect of chloramphenicol on protein synthesis in mammalian systems as com- 
pared to microbial systems. Presumably the initial steps in the maturation of 
erythrocytes require the formation and deposition of ribosomal template RNA 
capable of directing the synthesis of hemoglobin and of other proteins neces- 
sary for cellular development. In mammalian  cells template RNA  is stable, 
remaining firmly bound to the ribosome as long as the cell is capable of pro- 
tein synthesis and is not replenished (26). The possibility therefore exists that 
the increased susceptibility of primitive erythrocytes to chloramphenicol might 
be due to an inhibitory effect of the drug on either the ribosomal deposition or 
function of template RNA being formed during the initial phases of matura- 
tion  and  that  more  mature  cells  are  resistant  to  chloramphenicol because 
template RNA is already firmly bound to ribosomes. The present experiments 
were designed to simulate the sequence of events in maturing erythrocytes by 
stimulating the protein synthesis of reticulocyte ribosomes with added template 
RNA and then determining whether chloramphenlcol could inhibit this RNA- 
induced protein synthesis. Inhibition of protein synthesis induced by the added 
template RNA was demonstrable with low concentrations of chloramphenicol 
whereas  there was no significant inhibition of protein synthesis attributable 
to template RNA previously bound to the ribosome (endogenous protein syn- 
thesis). A preliminary report on some aspects of these studies has been pub- 
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Methods 
The cell-free system employed was  a  modification of those described by Matthaei and 
Nirenberg (6) and by Allen and Schweet (12), and consisted of rabbit reticulocyte ribosomes, 
a  supernatant factor prepared from reticulocytes, an energy generating system, amino acids, 
and buffer. The incorporation of U-C  a  L-leucine or U-C  14 L-phenylalanine into trichioracetic 
acid (TCA)-precipitable material was used as an index of protein synthesis. 
The basic plan of the experiments was to determine the increase in protein synthesis stimu- 
lated by added template RNA (synthetic or ribosomal) and then to determine the extent to 
which chioramphenicol could inhibit this induced protein synthesis. The net gain in C a  amino 
acid incorporation was determined by subtracting the amino acid incorporation obtained in 
control tubes from that obtained in the presence of stimulatory RNA.  The net gain with 
stimulatory RNA in the presence of chloramphenicol was then determined and the results 
expressed as per cent inhibition.  1 
Preparation of Ribosomes.--Reticulocytosis  was produced in white New  Zealand rabbits 
with phenylhydrazine by the method of Borsook et al. (28), and ribosomes were prepared by 
a  modification of the method of Allen and Schweet (12). Blood with a  reticulocyte count of 
85 to 95 per cent was obtained by cardiac puncture and washed with 0.13 ~  NaC1,  0.005 
KC1,  and 0.0075 ~  MgCI~. The packed cells were lysed with 4 volumes of 0.002 ~  MgC12, 
stirred at 4°C for 10 minutes, after which 1 volume of 1.5 ~r sucrose containing 0.15 K KC1 
was added. The mixture was stirred for 10 minutes and centrifuged at 15,000 g for 30 minutes 
at 4°C. The sediment was discarded and the supernate was centrifuged for 2 hours at 105,000 g 
in a  Spinco model L  preparative ultracentrifuge at 4°C.  The supernatant fluid was subse- 
quently used to prepare pH 5 enzyme (29). The ribosomal pellet was rinsed and resuspended 
in 0.002 u  MgCI~, 0.0175  ~r KHCOa,  and 0.25 ~r sucrose to the original volume, and then 
centrifuged at 4°C  for 1 hour at  105,000  g. This supernatant was discarded and the pellet 
rinsed with 0.25 ~  sucrose. The ribosomal pellet was then resuspended with 0.25 ~  sucrose 
in a  loose fitting glass homogenizer and the final volume adjusted so as to be equivalent to 
the original packed call volume. The ribosomal suspension was centrifuged at 15,000  g for 5 
minutes, the sediment discarded, and aliquots of the supernate, containing 1.5 to 3.0 mg pro- 
tein per ml, were stored at --65"C. The preparations retained activity for at least 4 weeks. 
Ribosomes were also obtained from the peripheral blood of patients with sickle cell anemia 
or from patients with pernicious anemia with reticulocytosis by the same method. 
Preparation of Supernatant Factors.--A  pH 5 enzyme containing soluble RNA, amino acid- 
activating enzymes, and transfer enzymes was prepared from reticulocytes by a modification 
of the method of Keller and Zamecnik (29) using the supernatant obtained after centrifuging 
the lysed reticulocytes for 2 hours at 105,000  g. This supernate contained large amounts of 
hemoglobin, and the procedure  to be described removed all but traces  of hemoglobin and 
other interfering substances. Three volumes of 0.9 xt sucrose, 0.004 ~  MgCI~, and 0.025 ~r KC1 
(medium B  of Keller and Zamecuik) were added to the reticulocyte supernate and the pH 
adjusted to 5.2 by slowly adding 1 ~  acetic acid. All solutions were kept at 4°C during this 
and subsequent preparative procedures. The precipitate was recovered by centrifugation at 
10,000  g for 15 minutes, washed with medium B, and then resuspended by homogenization 
in glass with 40 to 50 ml of medium B. The protein pellet was again collected by centrifugation 
at 30,000 g for 10 minutes. The pellet was rinsed with 0.35 ~ sucrose, 0.035 ~r KHCO3,0.004 
MgC1,, and 0.025 ~  KC1 (medium A of Keller and Zamecnik) and then dissolved in this same 
a Per cent inhibition -- 
net gain in  amino acid  incorporation with chloramphenicol 
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solution by homogenization. The final volume was adjusted to half the original packed cell 
volume. Insoluble protein was removed by centrifugation at 30,000 g  for  10 minutes. The 
supernatant solution, containing approximately 2  to 3  mg of protein per ml, was stored in 
aliquots at -65°C and retained activity for more than 4 weeks. Protein determinations were 
made by the Folin phenol method of Lowry (30). 
Preparation of Ribosomal Template RNA.--Ribosomal template RNA was isolated from 
ribosomes which had been stored in 0.25 M sucrose at -65°C by a phenol extraction method 
using freshly distilled phenol (7, 31). The concentration of the phenol was adjusted to 80 per 
cent with 0.02  x~ phosphate buffer, pH 7.2,  and the ribosomes were diluted with an equal 
volume of the same buffer. The ribosomal suspension was then shaken with an equal volume 
of 80 per cent phenol at room temperature for 15 minutes. The aqueous phase was aspirated 
from the phenol phase after centrifugation at 3900 g at 0°C for 5 minutes and was then ex- 
tracted two more times in the same manner, using ~  volume of 80 per cent phenol each time. 
The final aqueous phase was chilled to 4°C; 0.1 of the volume of 20 per cent sodium acetate 
and 0.01  of the volume of glacial acetic acid were added and the RNA precipitated with 2 
volumes of 95 per cent ethanol at -20°C. The suspension was centrifuged at 20,000 g for 15 
minutes and the supernate was discarded. The sediment was suspended by homogenization 
in glass using a  minimal volume of standard buffer 0.01 ~  tris, 0.01  x~ magnesium acetate, 
0.06 ~  KCI, pH 7.8). The RNA suspension was then dialyzed for 18 hours at 4°C against 100 
volumes of standard buffer with 2 changes of the dialyzing buffer. After dialysis, the RNA 
solution was centrifuged at 5000 g for 15 minutes. Both the supernate and the sediment (re- 
dissolved in standard buffer) were stored at 4°C and retained biologic activity for more than 4 
weeks. RNA content was estimated by the orcinol method, using d-ribose as a standard. The 
concentration of various RNA preparations used in these experiments ranged from 20 to 850 
micrograms per ml. 
Reaction Mixtures and Assay Techniques.--The  components of the reaction mixture were 
similar to those employed by Matthaei and Nirenberg (6). Each reaction mixture contained 
100/,moles of tris (hydroxymethyl) aminomethane, pH 7.8; 10/~moles magnesium acetate; 
50/~moles KC1; 6 vmoles mercaptoethanol; 0.05/~mole of 19 C  1~ L-amino acids  (9);  0.0045 
#mole of U-C  14 L-leucine (approximately 400,000 cpxr); 0.025 #mole guanosine triphosphate 
(GTP); 5/zmoles phosphoenolpyruvate (PEP); 1 #mole K~ATP; 20 #g of pyruvate ldnase; 0.2 
to 0.4 mg of pH 5 protein, and 0.15 to 0.25 mg of ribosomal protein. 
A  balanced amino acid mixture (M-l)  containing 19  C x~ L-amino acids,  standard buffer, 
mercaptoethanol, MgC12,  KCI,  and GTP was prepared so that 0.2 ml of the mixture con- 
tained the desired amounts of each compound and was stored at -65°C. Ribosomes, pH 5 en- 
zyme and M-1 were thawed immediately prior to each experiment; the desired  amounts of 
PEP (2.0 mg per each reactionmixture), K2ATP (0.7 mg per each reactionmixture), and kinase 
(0.002/zg protein per each reaction mixture) were added. Aliquots were added to tubes con- 
taining the desired amounts of chloramphenicol and RNA, and the final volume was adjusted 
to 1.0 ml with I-I20. All components were added at 4°C and incubation was then carried out in 
a water bath for 1 hour at 37°C. The reaction was terminated by the addition of 2 ml of 5  per 
cent TCA. The protein precipitate was collected by centrifugation, washed with 2 ml of 5 per 
cent TCA, and then extracted with 5 per cent TCA at 90°C for 20 minutes. The precipitate 
was again washed with 5 per cent TCA, washed twice with ethanol-ether (3:1), and then with 
anhydrous ether. The residue was dried, dissolved in 1.3 ml of concentrated formic acid, and 
1.0 ml aliquots were counted in a liquid scintillation counter (Nuclear-Chicago). 
When polyuridylic acid  (poly  U)  was used  to  stimulate protein synthesis, the reaction 
mixtures and assay techniques were identical with those employed above except that U-C  14 
L-phenylalanine incorporation was used as an index of protein synthesis instead of C  14 r.-leucine. A.  S.  WEISBERGER,  S.  WOLFE, AND  S.  ARMENTROUT  165 
Materials 
2-Phosphoenolpyruvic acid  (crystalline tricyclohexylammonium salt),  pyruvate  kinase 
(muscle)  A grade,  specific activity 168 to 254 enzyme traits/rag protein, and GTP were ob- 
tained from the California Corporation for Biochemical Research, Inc., Los Angeles.  ATP 
(dipotassium salt) was obtained from the Nutritional Biochemicals  Corporation, Cleveland. 
Uniformly labeled C  14 L-leucine (specific activity 50 to 112 mc/mmole) and U-C14-L-phenyl  - 
alanine (specific  activity  141 #c//zmole)  was  obtained  from  Schwarz  BioResearch,  Inc., 
Orangeburg, New York.  Crystalline chloramphenieol was supplied through the courtesy of 
Parke, Davis and Company, Detroit. The glucuronide of chloramphenicol was isolated from 
urine by Dr. Robert Greenway of Highland View Hospital, Cleveland. [CHaS] and [CHsSO~] 
analogs of ehloramphenicol were obtained through the courtesy of Dr. C. M. Suter, Sterling- 
Winthrop Research Institute, Rensselaer, New York. The aeeto analog of chloramphenicol 
was supplied by Warner-Lambert Research Institute, Morris Plains, New Jersey.  Strepto- 
mycin was  obtained from Nutritional Biochemicals Corporation.  Erythromycin base was 
furnished by Lilly Laboratory for Clinical Research,  Indianapolis. Crystalline tetracycline 
was furnished by American Cyanide Company, Pearl River, New York. Polyuridylic acid was 
purchased from Miles Chemical Company, Elkhart, Indiana. 
RESULTS 
Charact~t~s  of the Cell-Free Syst~.--The requirements for protein syn- 
thesis by reticuiocyte ribosomes were similar to those previously reported in 
analagous systems (6,  11,  12).  The amount of protein synthesis was directly 
proportional  to  the  mount  of  ribosomes  added  to  each  reaction  mixture. 
Omission of any component such as the energy generating system, superna- 
taut factors, or ribosomes resulted in absent or markedly reduced incorpora- 
tion of radioactive amino acids into TCA-precipitable protein. Since C  x4 amino 
acids of high specific activity were employed in these experiments, it was found 
that optimum protein synthesis was obtained if the amino acid mixtures were 
not made deficient in the corresponding C  12 amino acid. 
Stimulation of Protein Synthesis by Addition of Template  RNA Derived from 
Ribosomes.--Addition  of ribosomal template RNA to the cell-free  system re- 
suited in a marked increase in the incorporation of C  14 leucine into TCA-precipi- 
table material, the increase in protein synthesis being directly proportional to 
the amount of RNA added to each reaction mixture. In a typical experiment 
377 cPM (0.05 m/zmole)  of C  x4 leucine were incorporated into protein per 0.15 
mg of ribosomal protein in the absence of stimuiatory RNA. With the addition 
of increasing amounts of template I(NA to the system there was a  progressive 
increase in the incorporation of C  14 leucine. The protein synthesis induced by 
adding 348  #g  of template RNA resulted in the incorporation of  3748  cPM 
(0.46 re#mole) of C  14 leucine per 0.15 mg of ribosomal protein (Fig. 1). In other 
experiments, the maximum C  x4 leucine incorporation induced by added  tem- 
plate RNA amounted to as much as 14,454 cPM (1.8 m/zmoles) per 0.2 mg ribo- 
somal protein with 348 #g of RNA compared to 870 cP~ (0.11 m/~mole) of C  14 
leucine incorporation obtained with unstimulated ribosomes. 166  INHIBITION  OF  PROTEIN  SYNTHESIS 
The stimulatory activity of ribosomal template RNA varied with different 
preparations and was also dependent upon the state of the ribosomes. In various 
experiments, the net gain in C  14 leucine incorporation ranged up to 3200 cP~ 
per pg of added template RNA per mg ribosomal protein. The amount of C  14 
leucine bound by the added RNA in cell-free systems devoid of ribosomes was 
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FIG.  1.  Stimulation of reticulocyte ribosomal protein synthesis by template RNA isolated 
from ribosomes. Addition of template RNA to the cell-free systems resulted in an increased 
incorporation of C ~4 leucine into protein (induced protein synthesis), the increase being pro- 
portional to the amount of RNA added. The incorporation of C la leucine into protein is ex- 
pressed both as cP~ and mpmole per 0.15 mg of ribosomal protein. Approximately 10 cP~ (1 
##mole of C z4 leucine were incorporated into protein per #g of added RNA. In other experi- 
ments as much as 800 cP~ of C 14 leucine were incorporated per #g of added RNA using an 
equivalent amount of ribosomes. 
negligible. No attempt was made in any of these experiments to separate active 
components from the template RNA. 
Failure  to  obtain  stimulation  of protein  synthesis  with  added  RNA  was 
more often due to inadequate ribosomal activity rather than to inactivity of 
the added RNA. Preincubation of the ribosomes was usually necessary to ob- 
tain significant stimulation by the added RNA. Preincubation of the cell-free 
system was carried out for 30 minutes at 37°C in the absence of C  z4 leucine. 
After this initial incubation period, C z4 leucine was added, and aliquots of the A. S. WEISBERGER,  S. WOLFE, AND  S. AP,  MENTROUT  167 
completed  cell-free  system  were  pipetted  into  tubes  containing  the  desired 
amounts of RNA and buffer. Incubation was then carried out for an additional 
60 minutes before terminating the experiment by the addition of TCA. It was 
not necessary to replenish the energy-generating  system or to add additional 
pH  5  enzyme during  this  second  period  of incubation.  The  net  gain  in  C ~4 
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Fro. 2.  Stimulation of reticulocyte ribosomal protein synthesis by added template RNA. 
The amount of RNA-induced protein synthesis obtained with preincubated ribosomes is com- 
pared with that obtained with ribosomes not preincubated. The net gain in C  14 leucine in- 
corporation into protein with preincubated ribosomes is much greater than that  obtained 
with the unmodified ribosomes. The net gain in C  n leucine incorporation is expressed in el,~ 
per 0.2 mg ribosomal protein. 
leucine  incorporation  into  protein  was  much  greater  with  ribosomes  which 
were preincubated  (Fig.  2). Ribosomes stored for 4  weeks or longer at -65°C 
in the absence  of magnesium or subjected  to low magnesium concentrations 
for  1  hour at  room temperature  after  thawing  could  be  stimulated  without 
preincubation.  Optimum results were, however, obtained by preincubation of 
the ribosomes as described above and were uniformly employed in the experi- 
ments reported. 
Chloramphenicol Inhibition  of Protein Synthesis Induced by Added  Template 
RNA.--Chloramphenicol  inhibited  the  protein  synthesis  induced  by  added 168  INHIBITION OF  PROTEIN  SYNTHESIS 
TABLE I 
Inhibition  of  Induced  Ribosomal Protein  Synthesis  by  Chloramphenicol 
Complete system ....................................... 
Complete system -I- 1.0 ~mole chloramphenicol ............. 
Complete system +  2/~g template RNA ................... 
Complete system +  2/~g template RNA q- 0.0001 t~mole 
chloramphenicol ...................................... 
Complete system q- 2 t~g template RNA q- 0.001 t~mole 
chloramphenicol ...................................... 
Complete system -t- 2 ug template RNA +  0.01 t~mole 
chloramphenicol ..................................... 
Complete system +  2 #g template RNA +  0.1 #mole 
chloramphenicol ..................................... 
CPM 
790* 
720 
537 
438 
305 
007 
831 
~et 
cP~ 
~47 
~48 
~15 
H7 
41 
in  Inhibition 
per ant 
9 
0 
3O 
71 
95 
*  C  14 leucine incorporation expressed in CPM per 0.2 mg ribosomal protein. 
(Net gain in cP~r  )  Per cent inhibition =  100  \.  ~  X  100  . 
§ Equivalent to 0.095 m~mole of additional C 14 leucine incorporation. 
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FIG.  3.  Chloramphenicol inhibition of ribosomal protein synthesis induced by added tem- 
plate RNA. Protein synthesis occurring without added template RNA (endogenous)  was not 
significantly inhibited by chloramphenicol. In contrast,  the additional protein synthesis in- 
duced  by  added  template  RNA was  completely inhibited  by chloramphenicol.  Beginning 
inhibition was observed with 0.0001 micromole of chioramphenicol  (0.03  microgram per ml 
reaction mixture), and almost complete inhibition was obtained with 0.1  micromole (32 micro- 
grams). Reaction mixtures were added directly to the tubes containing 2 micrograms of RNA 
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template RNA but had comparatively little inhibitory effect on the unsfimu- 
lated (endogenous) protein synthesis Of ribosomes. For example, chlorampheni- 
col decreased endogenous ribosomal protein synthesis by less than 10 per cent 
when  present  in  concentrations  up  to  1.0  micromole  per  ml.  In  contrast, 
beginning  inhibition  of  the  protein  synthesis  induced  by  added  RNA  was 
usually obtained with 0.001  micromole of chloramphenicol  per  ml  but  could 
be obtained with as little as 0.0001  micromole of chloramphenicol per ml (Table 
I,  Fig.  3).  Almost  complete inhibition  of the  induced  protein  synthesis  was 
usually obtained with 0.1 micromole of chloramphenicol per ml. 
TABLE II 
Inhibition of Induced Ribosomal  Protein Synthesis by Chlorampheniool in Heterologous Systems 
[ 
Net gain [ Inhibition 
Rabbit reticulocyte ribosomes (0.29 mg protein)  +  rabbit liver ribosomal template RNA 
Complete system ......................................... 
Complete system -~ 97 #g RNA ........................... 
Complete system -b 97/zg RNA +  0.I ~mole 
chloramphenico|  ....................................... 
CPM 
1606 
2920 
1839 
CPM 
1314 
233 
per ¢eng 
82 
Rabbit reticulocyte  ribosomes  (0.25  mg protein)  +  dog liver ribosomal  template  RNA 
Complete system ........................................  267  --  -- 
Complete system +  38 #g RNA ...........................  583  276  -- 
Complete system +  38 #g RNA +  0.1 #mole 
ehloramphenieol  .......................................  351  84  70 
Human reticulocyte  ribosomes  (0.15  mg protein)  +  rabbit reticulocyte ribosomal  template  RNA 
Complete system ...... _.................................[  410  --  -- 
Completesystem-k2#gRNA............................[  7190  6780  -- 
Complete system -k 2/~g RNA -k 0.1 gmole ¢hloramphenieol . .[  480  70  99 
! 
Protein  synthesis  induced  by  template  RNA  derived  from  other  sources 
was also inhibited  by the  addition  of chloramphenicol.  Increased incorpora- 
tion of C 14 leucine into TCA-precipitable material was obtained when rabbit 
reticulocyte ribosomes were incubated with template RNA isolated from either 
rabbit liver ribosomes or dog liver ribosomes. In all instances almost complete 
inhibition of the induced protein synthesis was observed when chloramphenicol 
was added in a  concentration of 0.1  micromole per ml  (Table II). Similarly, 
addition  of rabbit reticulocyte template RNA to human  reticulocyte ribosomes 
resulted in an increase in protein synthesis which was completely inhibited by 
adding chloramphenicol in a concentration of 0.1  micromole per ml (Table II). 
The  effect of chloramphenicol in  blocking induced  protein  synthesis  could 170  I~tiI.BITION  OP PROTEIN SYNTH]~SIS 
not be overcome by adding increasing amounts of template RNA to the reac- 
tion mixture  (Fig.  4).  Essentially  the same percentage  of inhibition  was ob- 
tained  with  a  given  concentration  of  chloramphenicol  in  cell-free  systems 
stimulated  with  2 #g of template  RNA per ml as was obtained when 348 #g 
of RNA per ml was added. 
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Fio. 4. The effect of increasing amounts of added  template  RNA on chloramphenico] 
inhibition of induced protein synthesis. Chloramphenicol inhibition of induced protein synthe- 
sis could not be abolished by adding increasing amounts of template RNA. In this experiment 
essentially  the same percentage  of inhibition  was  obtained  with a  given concentration  of 
chloramphenicol whether  the cell-free system was stimulated  with 44 #g of RNA or 175 ~g 
of RNA. In other experiments similar results were obtained with RNA concentrations ranging 
from 2 to 348 ~g per ml reaction mixture. 
The  effect of chloramphenicol  on the  binding  of added  template  RNA by 
ribosomes was studied in the following manner. P~-labeled template RNA was 
prepared from E. coli K12 k  ribosomes and added to rabbit reticulocyte ribo- 
somes previously preincubated in a complete system. After 10 minutes' further 
incubation,  the  mixture  was  chilled  to  0°C  and  the  ribosomes  separated  by 
centrifugation at 105,000 g for 60 minutes at 4°C, washed with 0.25 ~r sucrose, 
and  dissolved  in  concentrated  formic  acid.  Similar  preparations  were  made 
in which chloramphenicol was added to the system together with the P~ RNA A.  S.  WEISBERGER,  S.  WOLFE,  AND  S.  ARBIENTROUT  171 
after preincubafion of the ribosomes. There was a progressive decrease in the 
amount of P32-1abeled RNA bound to the ribosomes with increasing concentra- 
tions of chloramphenicol, the maximum decrease being 50 per cent in the pres- 
ence of 0.1 #mole of chloramphenicol per ml (Table III). 
Chloramphenicol inhibited induced protein synthesis with equal effectiveness 
if added simultaneously with the stimulatory RNA or if present in the cell- 
free system prior to the addition of the RNA. There was a progressive decrease 
in the inhibitory effect of chloramphenicol  if it was  added after incubation 
with template RNA was begun, so that no significant inhibition was observed 
when chloramphenicol  was added 40 minutes after the RNA. 
Inhibition  of RNA-Induced  Protein Synthesis by Chloramphenicol Analogs 
TABLE  III 
The Effect of Chloramphenicol on Ribosomal Binding  of P32-Labeled Template RNA 
Ribosomes +  pS2 RNA ........................................ 
Ribosomes +  0.001 #mole chloramphenicol +  pS2 RNA ........... 
Ribosomes +  0.01 #mole chloramphenicol +  pSS RNA ............ 
Ribosomes +  0.1 #mole chloramphenicol +  pS2 RNA ............. 
Ribosomalb~ngof 
P~RNA* 
CPM$  p~ ~nt 
2090  100 
1600  79 
1550  69 
983  47 
* 15 #g P~ RNA/ml. 
:~ cI,•  per 0.2 mg ribosomal protein. 
and Other Antibiotics.--Inhibifion  of the increased  protein synthesis induced 
by added template RNA was also observed  with analogs  of chloramphenicol 
in which the N0, group is replaced by [CHsSO,], [CH3S] or aceto groups. These 
compounds have antiraicrobial  activity comparable  to that of chloramphenicol 
and were as effective as chloramphenicol in inhibiting induced protein synthesis 
(Table  IV).  In contrast, the glucuronide  detoxification  product of chloram- 
phenicol  which  has no antibiotic activity was  completely lacking  in an in- 
hibitory effect. 
The  effect  of streptomycin, tetracycline, erythromycin, and penicillin  on 
RNA-induced protein synthesis was also determined. None of these antibiotics 
inhibited protein synthesis by ribosomes to any significant extent in the absence 
of stimulatory RNA (endogenous protein synthesis).  When protein synthesis 
was stimulated with added template RNA, a 27 per cent inhibition of the in- 
duced protein synthesis was obtained with streptomycin (0.01 #mole  per ml) 
compared  to  a  73  per  cent inhibition obtained with  chloramphenicol  (0.01 
#mole per ml) under identical conditions. In the same experiment, addition of 
erythromycin (0.01 ]~mole per ml) resulted in 100 per cent inhibition, and addi- 
tion of  tetracycline (0.01 #mole  per  ml)  resulted  in  75  per  cent  inhibition 172  IN~tI~ITION  OF  PROTEIN"  SYNTHESIS 
whereas penicillin (1000 units per ml) was completely devoid of any inhibitory 
activity (Table IV). The inhibitory activity of streptomycin  did not  increase 
with greater concentrations of the drug, essentially the  same percentage of in- 
hibition being obtained with 0.1 ~mole as was  obtained with 0.001  #mole  per 
ml. Inhibition of induced protein synthesis by both  erythromycin and  tetra- 
cycline was linear with respect to concentration. 
Chloramphenicol  Inhibition  of Protein Synthesis Induced by Poly  U.--Addi- 
tion of poly U to a cell-free system also resulted in a marked increase in protein 
synthesis as measured by incorporation of C  u phenylaianine into TCA-precipi- 
table material  (Fig. 5). Manipulation of the ribosomes was not necessary to 
TABLE IV 
Inhibitory Effect of Other Antibiotics on  Induced Protein Synthesis 
Chloramphenicol, 0.01/~mole/ml  ............................... 
Chloramphenicol analogs 
CH3SO2 analog, 0.01 #mole/ml .............................. 
CH3S analog, 0.01/zmole/ml  ................................ 
Aceto analog, 0.01/zmole/ml  ................................ 
Chloramphenicol glucuronide, 0.01/zmole/ml  .................... 
Streptomycin, 0.01/zmole/ml  ................................. 
Erythromycin, 0.01/zmole/ml  ................................. 
Tetracycline, 0.01/zmole/ml  .................................. 
Penicillin, 1000 units/ml ...................................... 
Inhibition of induced 
protein synthesis 
per cenl 
73 
78 
68 
71 
0 
27 
100 
75 
0 
obtain poly U  stimulation; essentially the same amount of C  14 phenylalanine 
was incorporated when preincubated or non-preincubated ribosomes were used 
in the reaction mixtures. The maximum amount of stimulation was obtained 
when 75/~g per ml of poly U were added to the reaction mixture, the addition 
of larger amounts did not result in more incorporation of C  14 phenylalanine. 
Approximately 20/~#moles of phenylaianine were incorporated per  /~g of poly 
U added when 0.25 mg of ribosomes were present in the system. 
Inhibition of the protein synthesis induced by added poly U  was obtained 
with  chloramphenicol but  could be overcome by adding  increasing  amounts 
of poly U. Complete inhibition was obtained with 0.1 #mole of chloramphenicol 
per ml reaction mixture when poly U was added in amounts up to 2.5/zg per ml 
(Table V). A progressive decrease in the amount of inhibition  obtained with 
0.1/zmole of chloramphenicol was observed when the amount of poly U  added 
was increased, no chloramphenicol inhibition being obtained when 25/~g of poly 
U were present in the reaction mixture. 
Chloramphenicol inhibition occurred only if it was present in the reaction A.  S.  WEISBERGER~  S.  WOLFE~  AND  S.  ARMENTROUT  173 
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FIo. 5.  Stimulation of protein synthesis induced by polyuridyllc acid (poly U). Addition 
of increasing amounts of poly U resulted in an increased incorporation of C  1. phenylalanine 
into TCA-precipitable material. The maximum incorporation in this system was obtained 
with 75 #g of poly U per ml reaction mixture. Each reaction mixture contained 0.0014/zmole 
of 0  4 phenylalanine (approximately 420,000 c~), 0.05 #mole of C  12 phenylalanine, and 0.25 
nag of ribosomal protein per ml. Other components of the reaction mixture are as given in 
Methods. Approximately 200 cP~ of C  14 phenylalanine (25/zlzmoles of phenylalanine) were 
incorporated into protein per/zg of poly U added, when 0.25 nag of ribosomes were present in 
the reaction mixture. 
TABLE V 
Inhibition  of Protein S3ratkesis Induced by Polyuridylic Acid 
Amount of polyuridylic acid  Inhibition obtained with chloramphenicol 
(0.1 btmole/ml) 
~g/,,a 
1.0 
2.5 
5.0 
10.0 
25.0 
~er cent 
100 
100 
62 
17 
0 
mixture prior to the addition of poly U  or if added simultaneously with poly U. 
No inhibition was  demonstrable if chloramphenicol was  added after poly U. 
The  [CH3SO2],  [CHsS]  and aceto analogs of chloramphenicol were as effec- 
tive as chloramphenicol in decreasing protein synthesis induced by poly U. 174  IN'ftIBITION  OF  PROTEIN  SYNTHESIS 
DISCUSSION 
These experiments demonstrate that under certain conditions chlorampheni- 
col can inhibit protein synthesis in mammalian cell-free systems as effectively 
as  it  inhibits  protein  synthesis  in  analogous  microbial  systems.  Significant 
inhibition  in mammalian  systems was obtained only when protein synthesis 
was stimulated by the addition of template RNA to the system, there being 
comparatively little inhibition of protein synthesis in the absence of stimula- 
tory RNA.  Current  evidence indicates  that  protein  synthesis in  bacteria  is 
mediated by a continual supply of rapidly turning over RNA (32, 33) whereas 
in mammalian cells template RNA is comparatively stable, remaining  attached 
to the ribosomes as long as the cell is capable of protein synthesis (25). Since 
chloramphenicol  inhibits  protein  synthesis  in  mammalian  cell-free  systems 
only during the phase of addition of template RNA, the apparent discrepancy 
in the sensitivity of mammalian  and microbial cells to chloramphenicol  may 
be related to the known difference in rates of turnover or stability of template 
RNA, rather than to intrinsic differences in the mechanism of protein synthesis. 
These observations are in accord with the hypothesis that protein synthesis in 
intact mammalian cells may be susceptible to chloramphenicol  inhibition only 
at the time that new messenger or template RNA is being formed. More mature 
cells may be resistant to chloramphenicol  because informational RNA already 
deposited on  ribosomes is not  accessible  to  chloramphenicol  inhibition. 
There is now considerable evidence that chloramphenicol  may inhibit pro- 
tein synthesis in mammalian  cells either  by interfering  with the function of 
messenger  RNA or by blocking its  attachment  to  ribosomes.  Ambrose and 
Coons (14) recently suggested that chloramphenicol  may inhibit protein syn- 
thesis in mammalian cells by interfering  with messenger  RNA function. This 
suggestion  was based on the ability of low levels of chloramphenicol  to inhibit 
antibody synthesis in lymph node tissue cultures which were stimulated  by 
the  addition  of  antigen.  Inhibition  of  antibody  synthesis  was  obtained  if 
chloramphenicol  (0.15/zmole  per ml) was present in the culture medium for at 
least 6 days following the introduction of antigen.  It was suggested that  the 
continuous presence of chloramphenicol  in the culture media inhibited antibody 
synthesis by interfering  with the function of new messenger  RNA  formed in 
response to the antigenic stimulus. The inhibition  of protein synthesis in human 
bone marrow  cultures  exposed  to  prolonged  low  levels  of  chloramphenicol 
(0.12/zmole per ml) described by Djordjevic and Zybalski (13) may also be due 
to a similar mechanism. 
The  present  experiments  offer more direct  evidence that  chloramphenicol 
can inhibit the function of messenger  RNA. The results are in accord with the 
hypothesis that  chloramphenicol  inhibits  the function of template  RNA by 
blocking its  attachment  to  ribosome~  rather  than  by direct  inactivation  of 
RNA. Addition of increasing  amounts of template RNA to the cell-free system A.  S.  WEISBERGER~  S.  WOL]~E, AND  S.  ARMENTROUT  175 
did not alter or overcome the mount of inhibition attributable to a given con- 
centration of chloramphenicol.  If chloramphenicol  exerted its inhibitory effect 
by combining with template RNA to inactivate it,  the addition of increasing 
amounts of RNA should have resulted in a  progressive decrease in chloram- 
phenicol inhibition.  Kfican and Lipmann  (47) have also noted that chloram- 
phenicol inhibition is independent of the amount of E. coli m-RNA added to 
stimulate protein synthesis in microbial cell-free systems. Since chlorampheni- 
TEMPLATE  RNA 
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POLYPEPTIDE  SYNTHESIS 
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BLOCK~ 
Fro.  6.  Hypothesis on mechanism of action of chloramphenicol. The results of these studies 
suggest that chloramphenicol may inhibit protein synthesis in both bacterial and mammalian 
cells by interfering with the function of newly formed messenger or template RNA. Chloram- 
phenicol may interfere with the function of informational RNA by successfully  competing 
for ribosomal binding  sites and thereby preventing its attachment to ribosomal subunits. (AA, 
amino acid.) 
col does not inhibit protein synthesis in the absence of stimulatory RNA and 
since  chloramphenicol does not directly inactivate  template RNA, it is con- 
cluded that chloramphenicol may exert an inhibitory effect by interfering with 
the attachment of template RNA to ribosomes (Fig.  6). The decrease in ribo- 
somal binding of ps~ RNA in the presence of chloramphenicol  as demonstrated 
in the present report also suggests that this may be an important mechanism 
of action of chloramphenicol.  Jardetzky and Julian (46) have recently demon- 
strated  by  ultracentrifugation  studies  employing  sucrose  gradients,  that 
chloramphenicol  does prevent the binding of C  14 poly U to E. coli ribosomes, 
and  We have  confirmed  these  findings  with  labeled  RNA  and  reticulocyte 
ribosomes (34). Rendi and Ochoa (8) have previously suggested that chloram- 176  INHIBITION  OF  PROTEIN  SYNTHESIS 
phenicol  might interfere with the attachment of messenger  RNA to ribosomes 
basing  their  suggestion  on the accumulation  of messenger-like  RNA in bac- 
teria treated with chloramphenicol  (35-38). 
The mechanism by which chloramphenicol  might prevent the attachment of 
messenger  or template RNA to ribosomes is suggested by the studies of Jar- 
detzky  (39).  Jardetzky demonstrated  on the basis of nuclear  magnetic  reso- 
nance studies that the steric configuration  of chloramphenicol  bears a striking 
resemblance  to uridine-5'-phosphate.  Chloramphenicol  may therefore inhibit 
the binding  of new template RNA by competing with uridylic acid residues 
for ribosomal attachment.  Such inhibition  of binding between ribosomes and 
RNA would explain  why chloramphenicol  decreases  protein synthesis induced 
by added template RNA. Kdcan and Lipmann (47) have recently demonstrated 
in E. coli cell-free systems that protein synthesis stimulated by synthetic  co- 
polynucleotides containing guanylic acid (poly UG) or cytidylic acid (poly UC) 
can be inhibited by chloramphenicol.  These results are consistent with an  hy- 
pothesis that chloramphenicol  inhibits attachment of RNA to E. coli  ribosomes 
by competing with pyrimidine nucleotide residues. 
The polyribosomes, structures containing  several ribosomal subunits, proba- 
bly held together by messenger  RNA, are the major sites of protein synthesis 
in  reticulocytes (26, 40,  41).  These polyribosomes break down to  80S  units 
coincident with hemoglobin  synthesis (42).  It may be postulated that  in the 
present experiments, preincubation of the ribosomes results in a  dissociation 
of polyribosomes coincident with endogenous  protein synthesis and that added 
template RNA becomes associated with ribosomal subunits resulting in stimu- 
lation of protein synthesis. When chloramphenicol  is added to the system it 
inhibits the stimulatory effect of the added template by successfully competing 
for ribosomal binding sites,  thereby preventing the combination of RNA and 
ribosomal units necessary for the induction of protein synthesis. 
Although  the stimulation  of protein  synthesis with  added  template  RNA 
usually required  the  use  of preincubated  ribosomes,  poly U  stimulation  of 
protein synthesis was readily obtained with ribosomes which were not previously 
preincubated. Poly U may be more potent than natural polyribonucleotides in 
stimulating protein synthesis because of differences in binding to ribosomes or 
because the increased numbers of uridylic acid residues allow for more effective 
attachment  to ribosomes.  Similar  observations were made by Okarnoto  and 
Takanami (43) who demonstrated that poly U was more effective than natural 
polyribonucleotides  in  effecting  formation  of  polyribosome complexes.  The 
inability of chloramphenicol  to decrease poly U  stimulation  when added  10 
minutes after poly U, also suggests  that  poly U  attachment  to ribosomes is 
either more firm or more rapid than  that of added ribosomal template RNA. 
Template  RNA isolated from ribosomes may be less  effective  than  poly U 
because of the presence  of non-specific  RNA which may compete for binding 
sites but which is not effective in stimulating protein synthesis. A.  S.  WEISBERGER,  S.  WOLFE,  AND  S.  ARMENTROUT  177 
The ability of increasing  amounts of poly U to overcome chloramphenicol 
inhibition also suggests that there may be differences in the mode of action 
or differences in ribosomal binding  of poly U as compared  to template RNA 
isolated  from ribosomes. It seems unlikely that the inability of added ribo- 
somal template RNA to overcome chloramphenicol inhibition is due to adding 
inadequate amounts of active template RNA since no decrease  in chloram- 
phenicol  inhibition was observed  over a wide range. 
Inhibition of protein synthesis by chloramphenicol derivatives is correlated 
with the antimicrobial effect. Analogs of chloramphenicol formed by the substi- 
tution of the NO~ group by [CH3SO2], [CH3S] or aceto groups  are effective 
antimicrobial agents and were  as  effective  as  chloramphenicol  in inhibiting 
protein synthesis induced by added template RNA. In contrast, the glucuronide 
of chloramphenicol,  a detoxification product which has no antibacterial effect 
(44), was completely ineffective as an inhibitor of protein synthesis.  The ac- 
tivity of these derivatives of chloramphenicol  in inhibiting induced protein 
synthesis is in accord with the hypothesis that chloramphenicol inhibition may 
occur because of its steric resemblance to a pyrimidine nucleotide. The addition 
of glucuronic  acid  to  the propanediol  moiety of chloramphenicol  alters  the 
steric similarity to uridylic acid and results in the loss of antimicrobial effect 
as well as the loss of ability to inhibit protein synthesis. In comparison, substi- 
tution of the NO, group does not alter the steric  configuration,  and there is 
no loss of antimicrobial effect or a loss in the ability to inhibit protein synthesis. 
Streptomycin, erythromycin, and  tetracycline in  low  concentrations also 
inhibited protein synthesis induced by added RNA. Both erythromycin and 
tetracycline were  as  effective  as  chloramphenicol  in  inhibiting the  induced 
protein synthesis. These compounds  have previously been  shown  to have a 
mode of action similar to that of chloramphenicol in bacterial cell-free systems 
but were ineffective in mammalian cell-free systems unless excessive amounts 
of the drugs were employed. There is considerable evidence, however, that cell 
wall impermeability may exclude these drugs from sensitive  sites within the 
cell and it is unlikely that a ribosomal site of action is an important mechanism 
with these drugs (45). 
The ability of chloramphenicol  to inhibit induced protein synthesis both in 
mammalian cell-free systems and in tissue culture correlates with the observa- 
tions on the marked sensitivity of immature erythropoietic cells to chloram- 
phenicol.  In all  of these situations it may be  assumed  that the function of 
newly formed messenger RNA is inhibited by chloramphenicol. It is tempting 
to speculate  that similar  mechanisms  may be involved  in the hematopoietic 
toxicity observed with chloramphenicol therapy under ordinary circumstances. 
Duration of therapy as well as free chloramphenicol blood levels in relation to 
cell  turnover time may be  important factors in  the development of blood 
dyscrasias. 
Further evidence that chloramphenicol can inhibit de nova protein synthesis 178  INIIIBITION  OF PROTEIN  SYNTHESIS 
by mammalian cells is presented in the accompanying report on the inhibitory 
effect of chloramphenicol on antibody synthesis in dvo. 
SIYM~ARY 
Chloramphenicol can inhibit protein synthesis in mammalian cell-free sys- 
tems  as  effectively as  it  inhibits  protein  synthesis  in  analogous  microbial 
systems. Significant inhibition in mammalian systems was obtained only when 
protein  synthesis was  stimulated  by the  addition  of template  RNA  to  the 
system,  there  being  comparatively little  inhibition  d  protein  synthesis  by 
ribosomes in the absence of stimulatory RNA. It is postulated that chloram- 
phenicol may inhibit the function of messenger or template RNA by success- 
fully competing for ribosomal binding  sites,  thereby preventing the  attach- 
ment of RNA to ribosomes. 
The apparent discrepancy in  the  sensitivity of mammalian  and microbial 
cells to chloramphenicol may be related to differences in turnover or stability 
of ribosomal template RNA rather than to intrinsic differences in mechanism 
of protein synthesis. 
These observations are in accord with the suggestion that protein synthesis 
in intact mammalian  cells may be susceptible to chloramphenicol inhibition 
only at the time that new messenger or template RNA is being deposited on 
ribosomes and that more mature cells may be resistant because informative 
RNA  already  deposited  on  ribosomes  is  not  accessible  to  chloramphenicol 
inhibition.  The inhibitory effect of cMoramphenicol on protein  synthesis  in 
proliferating cells may be an important factor in hematologic toxicity attribu- 
table to chloramphenicol. 
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